Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (591-600 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparationR G Kiss, J M Stassen, H Deckmyn, et al.
Biochemical and Biophysical Research Communications|August 21, 2001
Targeted deletion of the cytosolic domain of tissue factor in mice does not affect developmentE Melis, L Moons, M De Mol, et al.
Circulation|March 1, 1992
Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study GroupH J Rapold, D de Bono, A E Arnold, et al.
Circulation|October 12, 2000
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarctionD Collen, P Sinnaeve, E Demarsin, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Praxis|March 6, 2010
[Glioblastoma multiforme--new hope due to modern therapeutical approaches]O P Gautschi, D Cadosch, T D Collen, et al.
Thrombosis and Haemostasis|February 23, 2002
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesityP E Morange, D Bastelica, M F Bonzi, et al.
Biochimica Et Biophysica Acta|February 16, 1994
Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26B Schlott, M Hartmann, K H Gührs, et al.
Circulation|June 1, 1991
Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombusH K Gold, T Yasuda, I K Jang, et al.
Pageof 72

Showing results (591-600 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|March 1, 1994
Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion graft preparationR G Kiss, J M Stassen, H Deckmyn, et al.
Biochemical and Biophysical Research Communications|August 21, 2001
Targeted deletion of the cytosolic domain of tissue factor in mice does not affect developmentE Melis, L Moons, M De Mol, et al.
Circulation|March 1, 1992
Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study GroupH J Rapold, D de Bono, A E Arnold, et al.
Circulation|October 12, 2000
Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarctionD Collen, P Sinnaeve, E Demarsin, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Praxis|March 6, 2010
[Glioblastoma multiforme--new hope due to modern therapeutical approaches]O P Gautschi, D Cadosch, T D Collen, et al.
Thrombosis and Haemostasis|February 23, 2002
Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesityP E Morange, D Bastelica, M F Bonzi, et al.
Biochimica Et Biophysica Acta|February 16, 1994
Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26B Schlott, M Hartmann, K H Gührs, et al.
Circulation|June 1, 1991
Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombusH K Gold, T Yasuda, I K Jang, et al.
Pageof 72